BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 17186383)

  • 1. Bone marrow cells in the 'pre-metastatic niche': within bone and beyond.
    Kaplan RN; Psaila B; Lyden D
    Cancer Metastasis Rev; 2006 Dec; 25(4):521-9. PubMed ID: 17186383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin.
    Dimitroff CJ; Lechpammer M; Long-Woodward D; Kutok JL
    Cancer Res; 2004 Aug; 64(15):5261-9. PubMed ID: 15289332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bone marrow-derived cells contribute to niche formation in cancer progression].
    Hattori K; Ishihara M; Heissig B
    Clin Calcium; 2008 Apr; 18(4):480-7. PubMed ID: 18379030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow-derived cells: roles in solid tumor. Minireview.
    Wu XZ; Chen D; Xie GR
    Neoplasma; 2007; 54(1):1-6. PubMed ID: 17203886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model.
    Moreau JE; Anderson K; Mauney JR; Nguyen T; Kaplan DL; Rosenblatt M
    Cancer Res; 2007 Nov; 67(21):10304-8. PubMed ID: 17974972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic process of prostate cancer metastasis to bone.
    Tantivejkul K; Kalikin LM; Pienta KJ
    J Cell Biochem; 2004 Mar; 91(4):706-17. PubMed ID: 14991762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bone microenvironment in metastasis; what is special about bone?
    Bussard KM; Gay CV; Mastro AM
    Cancer Metastasis Rev; 2008 Mar; 27(1):41-55. PubMed ID: 18071636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of vascular endothelial growth factor receptor 1-positive hematopoietic progenitor cell clusters in human colorectal carcinoma metastasis].
    Yang ZH; Yang M; Xiong HZ; Li XN
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):696-9. PubMed ID: 18504182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current trials using bone-targeting agents in prostate cancer.
    Tu SM; Lin SH
    Cancer J; 2008; 14(1):35-9. PubMed ID: 18303481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular basis of cancer metastasis: A review of fundamentals and new advances.
    Oppenheimer SB
    Acta Histochem; 2006; 108(5):327-34. PubMed ID: 16730054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteotropic cancers: from primary tumor to bone.
    Buijs JT; van der Pluijm G
    Cancer Lett; 2009 Jan; 273(2):177-93. PubMed ID: 18632203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Niche-to-niche migration of bone-marrow-derived cells.
    Kaplan RN; Psaila B; Lyden D
    Trends Mol Med; 2007 Feb; 13(2):72-81. PubMed ID: 17197241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravascular cell-to-cell adhesive interactions and bone metastasis.
    Glinsky VV
    Cancer Metastasis Rev; 2006 Dec; 25(4):531-40. PubMed ID: 17171440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts.
    Peinado H; Lavotshkin S; Lyden D
    Semin Cancer Biol; 2011 Apr; 21(2):139-46. PubMed ID: 21251983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status in human breast cancer micrometastasis.
    Alix-Panabières C; Müller V; Pantel K
    Curr Opin Oncol; 2007 Nov; 19(6):558-63. PubMed ID: 17906452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.
    Mori K; Le Goff B; Charrier C; Battaglia S; Heymann D; Rédini F
    Bone; 2007 Apr; 40(4):981-90. PubMed ID: 17196895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A paradigm for the treatment of prostate cancer bone metastases based on an understanding of tumor cell-microenvironment interactions.
    Loberg RD; Gayed BA; Olson KB; Pienta KJ
    J Cell Biochem; 2005 Oct; 96(3):439-46. PubMed ID: 15988761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasis.
    Bonfil RD; Chinni S; Fridman R; Kim HR; Cher ML
    Urol Oncol; 2007; 25(5):407-11. PubMed ID: 17826661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alpha-receptor for platelet-derived growth factor as a target for antibody-mediated inhibition of skeletal metastases from prostate cancer cells.
    Russell MR; Jamieson WL; Dolloff NG; Fatatis A
    Oncogene; 2009 Jan; 28(3):412-21. PubMed ID: 18850002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of tumour angiogenesis and tumour cells in bone marrow in gastric cancer patients.
    Gretschel S; Astrosini Ch; Vieth M; Jöns T; Tomov T; Höcker M; Schlag PM; Kemmner W
    Eur J Surg Oncol; 2008 Jun; 34(6):642-7. PubMed ID: 18023552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.